Cheaper medicines for people fighting cancer and rare diseases

1 April 2026 - The Albanese Government is continuing to deliver cheaper medicines with Australians living with debilitating conditions including ...

Read more →

Schedule of Pharmaceutical Benefits - 1 April 2026

1 April 2026 - The April 2026 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Leading cancer drug subsidised for thousands of patients

29 March 2026 - Health Minister Mark Butler has expanded the PBS listing of a leading cancer drug, giving more than ...

Read more →

Expanded immunotherapy PBS listing to treat more cancers

29 March 2026 - The Albanese Government is continuing to deliver cheaper medicines with thousands more Australians living with advanced ...

Read more →

New multi-indication PBS listing for two immunotherapy treatments from March 2026

1 March 2026 - Bristol Myers Squibb Australia confirms that Opdivo (nivolumab) and Yervoy (ipilimumab) will be listed on the ...

Read more →

World first cheaper immunotherapy treatment listing for patients with advanced or rare cancers

1 March 2026 - From today, thousands more Australians living with advanced and rare cancers will have access to affordable ...

Read more →

More cheaper medicines to help Australians fight complex and chronic illness

2 March 2026 - Australians living with auto-immune disease, lymphoma, Parkinson's, motor neuron disease and cerebral palsy will have access ...

Read more →

Schedule of Pharmaceutical Benefits - 1 March 2026

1 March 2026 - The March 2026 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New PBS listing for immunotherapy cancer drugs Opdivo and Yervoy to be slashed

2 March 2026 - Patients with advanced and rare cancers will be able to access two immunotherapy drugs for just $25, ...

Read more →

Cheaper medicines for chronic kidney disease and psoriasis

16 February 2026 - Australians with chronic kidney disease and psoriasis will now have access to cheaper medicines for each ...

Read more →

Affordable eczema drug Dupixent still out of reach for children

14 January 2026 - Children under 12 with severe eczema face $20,000 yearly costs for life changing treatment despite medical experts ...

Read more →

Health Minister ‘committed’ to listing weight loss drugs on PBS

9 January 2026 - ‘It’s an equity issue as well as a health issue from my perspective.’ ...

Read more →

Cheaper medicines for children's inflammatory diseases, rare liver disease and multiple sclerosis

8 January 2026 - Australians living with a range of debilitating conditions including juvenile arthritis, rare liver disease and multiple ...

Read more →

Schedule of Pharmaceutical Benefits - 1 January 2026

1 January 2026 - The January 2026 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

Cheaper multiple sclerosis and rare cancer medicines now on PBS

4 December 2025 - Australians living with multiple sclerosis and rare cancers will now have access to life-changing medicines thanks ...

Read more →